Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intracranial artery stenting shows promising 1-year results

Key clinical point: One-year follow-up of on-label stenting of intracranial arteries showed a suggestion of efficacy.

Major finding: The death or stroke rate was 9% after intracranial stent placement, compared with a 12% rate in historical controls.

Study details: WOVEN, an extended follow-up of 129 patients enrolled in the WEAVE multicenter, randomized study.

Disclosures: WEAVE was sponsored by Stryker Neurovascular, the company that markets the Wingspan intracranial artery stent. WOVEN received no commercial funding. Dr. Alexander has been a consultant to Stryker Neurovascular.


Alexander MJ et al. ISC 2020, Abstract LB4.